GLP-1 medications and PCOS: what the research actually supports

What did @gianamj actually say?

Here's the uncomfortable truth about this video: the transcript contains no medical claims at all. What was captured word-for-word is song lyrics, not a health explainer. The actual audio is a rap or pop track with lines like "I'm about to shoot my shot" and "my favorite outfit is her seat through, bumper." None of it touches GLP-1 medications, PCOS, or insulin resistance.

The caption, however, does make real claims worth examining. @gianamj wrote that GLP-1 medications "may support certain metabolic patterns seen in PCOS, particularly those involving insulin resistance," and noted that "it's often extremely difficult for PCOS patients to get" access to these drugs. Those are the claims we can actually evaluate, because the video itself, based on what was said aloud, contains zero medical content.

Does the science back this up?

The caption's core claim, that GLP-1s may help with insulin resistance in PCOS, is directionally supported by emerging evidence, though the research is still thin and mostly small-scale. This is a case where the science is promising but nowhere near settled.

A 2023 randomized controlled trial by Salamun et al. published in Reproductive BioMedicine Online found that liraglutide improved insulin sensitivity and reduced androgen levels in women with PCOS compared to placebo. A 2022 review by Jensterle et al. in Frontiers in Endocrinology examined GLP-1 receptor agonists across multiple PCOS studies and concluded that weight-independent metabolic improvements were observed, meaning the benefit wasn't purely from losing weight. That's a meaningful distinction. Semaglutide specifically has been less studied in PCOS populations, though trials are underway. The honest read of the literature: real signal, not enough data yet to call it standard of care.

What did they get wrong (or right)?

Credit where it's due: the caption language is appropriately hedged. Phrases like "may be helpful" and "emerging research suggests" are accurate descriptions of where the science stands. That kind of epistemic humility is rarer than it should be in health TikTok. No one is claiming a cure, no doses are recommended, and the framing sticks to metabolic patterns rather than making sweeping hormonal promises.

The access point is also legitimate. GLP-1s are FDA-approved for type 2 diabetes and obesity, not PCOS. That means most insurers won't cover them for PCOS patients even when a clinician thinks they're appropriate. A 2023 analysis in JAMA Health Forum by Dusetzina et al. documented significant coverage gaps for GLP-1 medications, particularly for off-label indications. So the claim that access is "extremely difficult" for PCOS patients isn't an exaggeration. It reflects a real structural problem in how these drugs are covered.

What's missing is any mention of first-line PCOS metabolic treatments like metformin, lifestyle intervention, or inositol supplementation, all of which have more established evidence in this population. Framing GLP-1s without that context creates an incomplete picture.

What should you actually know?

If you have PCOS with insulin resistance, GLP-1 medications are not the starting point most clinicians would recommend right now, and they are not approved for PCOS. Metformin has decades of data in this population. A 2021 Cochrane review by Naderpoor et al. confirmed metformin improves ovulation rates and metabolic markers in PCOS with a much stronger evidence base than GLP-1s currently have.

That doesn't mean GLP-1s are off the table. For patients who haven't responded to first-line options, or who have comorbid obesity or type 2 diabetes, a prescriber might consider them. But that's a clinical conversation, not a TikTok decision. The caption here doesn't push anyone toward a specific drug or dose, which is the right call. What it does do is raise awareness of a real and evolving area of research. For a 21-second caption, that's actually a reasonable contribution, as long as viewers don't mistake "emerging research suggests" for "this is proven and available to you."

Bottom line on the video itself

The audio transcript is song lyrics with no medical relevance. The fact-checkable content lives entirely in the caption. That caption is mostly responsible, appropriately hedged, and points toward real science, even if it skips the important context of what treatments currently come before GLP-1s in PCOS management. The access barrier point is accurate and underreported. The science framing is honest. This one clears the bar, just barely, and only because of what wasn't said, not what was.